Trials / Completed
CompletedNCT02445378
Aromatherapy and Essential Oils in Improving Insomnia and Other Symptoms in Patients With Newly Diagnosed Acute Leukemia Undergoing Chemotherapy
The Effect of Aromatherapy on Insomnia and Other Common Cancer Patient Symptoms
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Ohio State University Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This randomized clinical trial studies aromatherapy and essential oils in improving insomnia and other symptoms in patients with newly diagnosed acute leukemia. Aromatherapy and essential oils may help improve insomnia and other complications caused by chemotherapy.
Detailed description
PRIMARY OBJECTIVES: I. Does the addition of aromatherapy by diffusion of essential oils improve insomnia in newly diagnosed, hospitalized leukemia patients? SECONDARY OBJECTIVES: I. Does the addition of aromatherapy by diffusion of essential oils improve other common symptoms in newly diagnosed, hospitalized leukemia patients, including pain, nausea, lack of appetite, shortness of breath, depression, anxiety and wellbeing? II. Do newly diagnosed, hospitalized leukemia patients find the use of aromatherapy for symptom management a positive experience? OUTLINE: Patients are randomized to 1 of 2 groups. GROUP I: Patients select between 3 scented essential oils: peppermint, lavender, or chamomile which is diffused in the hospital room from approximately 9 PM in the evening until morning during week 1 and placebo intervention using rose water during week 2. GROUP II: Patients undergo placebo intervention using rose water during week 1 and aromatherapy and essential oils as in Group I during week 2.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Aromatherapy and Essential Oils | Undergo aromatherapy and essential oils |
| OTHER | Placebo | Undergo placebo intervention using rose water |
| OTHER | Questionnaire Administration | Ancillary studies |
Timeline
- Start date
- 2014-12-28
- Primary completion
- 2016-09-01
- Completion
- 2016-11-05
- First posted
- 2015-05-15
- Last updated
- 2019-04-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02445378. Inclusion in this directory is not an endorsement.